Pjp prophylaxis steroids

The information contained in this protocol is based on the highest level of available evidence and consensus of the eviQ reference committee regarding their views of currently accepted approaches to treatment. Any clinician (medical oncologist, haematologist, radiation oncologist, medical physicist, radiation therapist, pharmacist or nurse) seeking to apply or consult this protocol is expected to use independent clinical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use is subject to eviQ’s disclaimer available at

Pneumonia caused by P. jirovecii (formerly called P. carinii ) is an opportunistic infection most commonly associated with the human immunodeficiency virus (HIV). However, individuals who are immunosuppressed for other reasons, such as those undergoing treatment for organ transplantation or connective tissue diseases with steroids and other immunosuppressants also are at risk of PJP. Wicks and colleagues recently reported that % of patients with PJP seen at the Royal Melbourne Hospital had an underlying connective tissue disease.

Pjp prophylaxis steroids

pjp prophylaxis steroids


pjp prophylaxis steroidspjp prophylaxis steroids